Overall Perfomance for "Ultimate Stock Alerts"
The following three charts can be used by potential investors to gauge the performance of "Ultimate Stock Alerts":
2 out of 7 campaigns closed down on first day
2 out of 7 campaigns closed up on first day
3 out of 7 campaigns had no net effect
XXII Promotional Newsletter
The following is a newsletter released by "Ultimate Stock Alerts" promoting 22nd Century Group, Inc.
Don't Want Anymore Emails
XXII, our newest alert, released breaking news this morning that could be another growth catalyst for the company.
22nd Century Group Nasdaq XXII Acquires GVB Biopharma, a Leading HempCannabis Company
Here are the highlights from this press release
Provides Transformational Platform to Rapidly Grow HempCannabis Franchise
Transaction Immediately Accretive and Will Double Companys Total Revenue
Adds Significant Commercial Scale to Existing HempCannabis Franchise
GVB Biopharma has Achieved Strong Growth and Leading Market Share in Hemp-Derived Active Ingredients
As the company further explains
As a contract development and manufacturing organization CDMO, GVB is believed to be one of the largest providers of hemp-derived active ingredients for the pharmaceutical and consumer goods industries worldwide based on total tonnage.
GVB is widely regarded as a best-in-class operator with an estimated 15% share of the hemp-derived active ingredients market. The company is a trusted supplier to leading CBD and cannabinoid brands, including Cookies, Nuleaf and Canaxis Pharma. GVBs formulation capabilities and GMP certified facilities are uniquely suited to manufacture vastly improved pharmaceutical and consumer goods products that leverage and monetize 22nd Centurys proprietary plant genetics and research capabilities.
GVB is also well positioned to lead international expansion, including multiple international joint ventures in Europe to co-develop and co-own processing and distribution companies aligned to market needs. GVB currently has offices in the United Kingdom and Brussels.
GVBs strengths complement 22nd Centurys existing upstream and downstream value chains, which includes expertise in cannabinoid receptor science with CannaMetrix, plant research and proprietary genetics through its KeyGene partnership, breeding expertise with Extractas, and cultivation capabilities at Needle Rock Farms. The combination with 22nd Century establishes a global one-of-a-kind asset to serve the rapidly growing hempcannabis ingredient market.
GVB expects 2022 revenue of approximately $48 million, a 58% increase year-over-year, gross margin in excess of 44% and positive cash flow. Upon closing, the transaction is expected to more than double 22nd Centurys revenue, be immediately accretive to adjusted EBITDA, and generate positive cash flow from the acquired assets in the near term.
Here are the companys comments from this press release
James A. Mish, chief executive officer of 22nd Century Group, stated GVB represents a transformational acquisition for 22nd Century that will enable us to rapidly grow our hempcannabis franchise. GVB is one of the largest CBD suppliers globally, possessing innovative, vertically integrated cannabinoid product manufacturing technologies driving industry leading scale and cost efficiency. In addition to immediately expanding our hempcannabis franchise capabilities, GVB represents an opportunity to double our revenue and internalize a comprehensive contract manufacturing and extraction platform which can be used to directly and exclusively monetize our differentiated and proprietary hempcannabis plant genetics and intellectual property. We are enthusiastic to begin working with the highly regarded and very experienced management team at GVB.
We are excited to combine with 22nd Century group, pairing our production and manufacturing capabilities together with the best hempcannabis plant science in the world, said Phillip Swindells, Chief Executive Officer at GVB. Since 2017, we have built a loyal customer base and continue to add new, rapidly growing customers as demand in our industry accelerates. We sold more than five billion doses of CBD in 2021, and we look forward to further scaling our business as a part of 22nd Centurys comprehensive platform.
As the company further accomplishes its plans, it could position itself for increased opportunity.
Sources , , , , , , , , , , , ,
Note We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term opportunities. Before investing in securities, you should always consult with your financial, tax and legal advisor and never invest money you cannot afford to lose.
You should read and understand this disclaimer in its entirety before joining the website or emailblog list of UltimateStockAlerts.com the Publisher. The information collectively the Advertisement disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, andor losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply.
The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission the SEC at www.sec.gov the Financial Industry Regulatory Authority the FINRA at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.govconsumercyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.
The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial andor legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.
Owners and operators of the Publisher have been compensated twelve thousand five hundred dollars by bank wire transfer on 51322 for the distribution of this advertisement about XXII dated 51322. Previously, owners and operators of the Publisher have been compensated twenty five thousand dollars by bank wire transfer on 82321 for the distribution of a prior advertisement about XXII. Previously, owners and operators of the Publisher have been compensated twenty five thousand dollars by bank wire transfer on 62521 for the distribution of a prior advertisement about XXII. Prior to the past year, at the time of publication, we disclosed our compensation for the distribution of advertisements about XXII. The Publisher and its owners and operators hold no stocks or bonds in companies discussed in the Advertisement. Owners and operators of the Publisher own several newsletters, therefore you may receive multiple publications and emails featuring companies at different or the same time.
www.UltimateStockAlerts.comDisclaimer and www.UltimateStockAlerts.comPrivacy-Policy
By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of 1 a client company, 2 the party issuing or preparing the information for the company, or 3 other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated reportrelease or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.
Our records indicate that . requested and confirmed to be added to UltimateStockAlerts.com on January 26, 2015.
6020 Bent Pine Dr, Orlando, FL 32822, USA
Last 1 Stock Promotions By "Ultimate Stock Alerts"
|PURE||PURE Bioscience||May 11, 2022||0.166||-7%|